Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
June 24 (Reuters) - Capricor Therapeutics Inc CAPR.O:
CAPRICOR THERAPEUTICS PROVIDES REGULATORY UPDATE ON DERAMIOCEL BLA FOR DUCHENNE MUSCULAR DYSTROPHY
CAPRICOR THERAPEUTICS INC - FDA ADVISORY COMMITTEE MEETING NOT REQUIRED FOR DERAMIOCEL
CAPRICOR THERAPEUTICS INC - LATE-CYCLE REVIEW MEETING SCHEDULED FOR MID-JULY FOR DERAMIOCEL BLA
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Precious Metals May Outlook: After U.S.-Iran Conflict Concerns Eased, Will Funds Flow Back to Gold and Silver?

Is SanDisk the Hidden Gem of the AI Boom in 2026? Discover the Potential Risks and Rewards.

Intel vs. TSM: Which Semiconductor Stock Looks Like the Better Investment?

What Is Intel, and Is Its Stock Still a Worthwhile Investment?

Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?

Tradingkey








